oxazolidin-2-one has been researched along with radezolid in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 6 (54.55) | 2.80 |
| Authors | Studies |
|---|---|
| Appelbaum, PC; Kosowska-Shick, K; Lemaire, S; Tulkens, PM; Van Bambeke, F; Verween, G | 1 |
| Lemaire, S; Tulkens, PM; Van Bambeke, F | 1 |
| Deshpande, LM; Jones, RN; Mendes, RE | 1 |
| Fulle, S; Gohlke, H; Homeyer, N; Saini, JS | 1 |
| Bocian, W; Cielecka-Piontek, J; Gruba, E; Michalska, K | 1 |
| Chen, JW; Chen, Z; Qu, D; Sun, X; Xu, GJ; Xu, ZC; Yu, ZJ; Zheng, JX | 1 |
| Ding, X; Duan, M; Hou, Y; Jiang, J; Wang, B; Wu, Y; Zhao, Y | 1 |
| Makarov, GI; Reshetnikova, RV | 1 |
| Bednarek, E; Bocian, W; Michalska, K | 1 |
| Fraser, JS; Fujimori, DG; Klepacki, D; Lee, DJ; Mankin, AS; Stojković, V; Szal, T; Tsai, K; Vázquez-Laslop, N; Young, ID | 1 |
| Crowe-McAuliffe, C; Wilson, DN | 1 |
1 review(s) available for oxazolidin-2-one and radezolid
| Article | Year |
|---|---|
Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Proteins; Drug Approval; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Mutation; Oxazolidinones; Ribosomal Protein L3; Ribosomal Proteins; RNA, Ribosomal, 23S; Tetrazoles | 2014 |
10 other study(ies) available for oxazolidin-2-one and radezolid
| Article | Year |
|---|---|
Cellular pharmacodynamics of the novel biaryloxazolidinone radezolid: studies with infected phagocytic and nonphagocytic cells, using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cells, Cultured; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Humans; Legionella pneumophila; Linezolid; Listeria monocytogenes; Microbial Sensitivity Tests; Oxazolidinones; Phagocytes; Rats; Staphylococcus aureus; Staphylococcus epidermidis | 2010 |
Cellular pharmacokinetics of the novel biaryloxazolidinone radezolid in phagocytic cells: studies with macrophages and polymorphonuclear neutrophils.
Topics: Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Biological Transport, Active; Cell Line; Culture Media; Half-Life; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Ionophores; Macrophages; Mice; Monensin; Neutrophils; Oxazolidinones; Phagocytes; Protein Binding; Temperature | 2010 |
Complex long-distance effects of mutations that confer linezolid resistance in the large ribosomal subunit.
Topics: Anti-Bacterial Agents; Binding Sites; Drug Resistance, Bacterial; Linezolid; Molecular Dynamics Simulation; Mutation; Nucleotides; Oxazolidinones; Protein Synthesis Inhibitors; Ribosome Subunits, Large, Archaeal | 2015 |
Enantioselective recognition of radezolid by cyclodextrin modified capillary electrokinetic chromatography and electronic circular dichroism.
Topics: Capillary Electrochromatography; Circular Dichroism; Cyclodextrins; Oxazolidinones; Stereoisomerism | 2017 |
In vitro evaluation of the antibacterial activities of radezolid and linezolid for Streptococcus agalactiae.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Molecular Typing; Oxazolidinones; RNA, Ribosomal, 23S; Streptococcal Infections; Streptococcus agalactiae | 2020 |
Design, synthesis and antibacterial evaluation of novel oxazolidinone derivatives nitrogen-containing fused heterocyclic moiety.
Topics: Anti-Bacterial Agents; Drug Design; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Nitrogen; Oxazolidinones; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
Investigation of radezolid interaction with non-canonical chloramphenicol binding site by molecular dynamics simulations.
Topics: Anti-Bacterial Agents; Binding Sites; Chloramphenicol; Escherichia coli; Molecular Dynamics Simulation; Oxazolidinones | 2021 |
Explanation of the Formation of Complexes between Representatives of Oxazolidinones and HDAS-β-CD Using Molecular Modeling as a Complementary Technique to cEKC and NMR.
Topics: beta-Cyclodextrins; Cyclodextrins; Electrophoresis, Capillary; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Models, Molecular; Oxazolidinones; Stereoisomerism; Tetrazoles | 2021 |
Structural basis for context-specific inhibition of translation by oxazolidinone antibiotics.
Topics: Alanine; Anti-Bacterial Agents; Binding Sites; Cryoelectron Microscopy; Linezolid; Models, Molecular; Oxazolidinones; Peptidyl Transferases; Protein Biosynthesis; Ribosomes; RNA, Ribosomal; RNA, Transfer | 2022 |
Putting the antibiotics chloramphenicol and linezolid into context.
Topics: Anti-Bacterial Agents; Bacteria; Chloramphenicol; Drug Development; Drug Resistance, Bacterial; Humans; Linezolid; Models, Molecular; Oxazolidinones; Protein Biosynthesis; Protein Synthesis Inhibitors; Ribosomes; Structure-Activity Relationship | 2022 |